Recently, another study demonstrated miR-122 serum levels were robustly increased early on in a diet-induced model of NAFLD and correlated with ALT and AST levels, and supports the notion that reductions in hepatocytic miR-122 correlates to and can indicate inflammation in the setting of NASH [19]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.